Results 191 to 200 of about 68,288 (264)

Welcome Pathogens: Transient Heat Dampens Immune Responses to Acibenzolar‐S‐Methyl in Apple Plants

open access: yesPlant, Cell &Environment, Volume 49, Issue 3, Page 1229-1248, March 2026.
ABSTRACT Climate change affects plant‐pathogen interactions, with disease outcome varying depending on the pathosystem and environmental scenario. In Arabidopsis, a thermo‐sensitive module of salicylic acid (SA) signalling makes immunity vulnerable to heat.
Erwan Chavonet   +10 more
wiley   +1 more source

Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancer. [PDF]

open access: yesSci Rep
McVey JC   +12 more
europepmc   +1 more source

Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 2, March/April 2026.
ABSTRACT Third‐generation epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR‐TKIs) are standard first‐line therapy for advanced, EGFR‐mutated nonsmall cell lung cancer (NSCLC). However, their benefit is limited in patients who have co‐existing tumor suppressor gene (TSG) mutations, highlighting a need for intensified strategies to ...
Jian‐Chun Duan   +25 more
wiley   +1 more source

Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 2, March/April 2026.
Abstract Genomics—and genomic testing in particular—has transformed oncology, facilitating both targeted therapies and personalized care. In pediatric oncology, unique clinical and ethical considerations arise. Compared with adults, children and adolescents are affected by more limited evidence regarding test performance, variant interpretation, and ...
Brittany L. Greene, Jonathan M. Marron
wiley   +1 more source

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

open access: yesHuman Mutation, 2018
T. Rebbeck   +241 more
semanticscholar   +1 more source

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan. [PDF]

open access: yesSci Rep
Samigatova A   +8 more
europepmc   +1 more source

Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer. [PDF]

open access: yesSci Rep
Oswald AJ   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy